Nectar Lifesciences - Quaterly Results

13 Aug 2022 Evaluate
The company's total revenue for the quarter ended June 2022 saw a slight change in the total revenue, having registered a total revenue of Rs. 4030.23 millions.Profit for the quarter ended June 2022 rises by 90.24% to Rs. 39.36  millions from Rs. 20.69 millions.OP of the company witnessed a marginal growth to 422.09 millions from 407.87 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 4030.23 3844.53 4.83 4030.23 3844.53 4.83 16682.56 15428.96 8.12
Other Income 3.64 51.46 -92.93 3.64 51.46 -92.93 112.93 27.22 314.88
PBIDT 422.09 407.87 3.49 422.09 407.87 3.49 1701.31 1129.49 50.63
Interest 213.66 257.45 -17.01 213.66 257.45 -17.01 788.10 1120.32 -29.65
PBDT 208.43 150.42 38.57 208.43 150.42 38.57 913.21 -243.98 -474.30
Depreciation 146.95 142.78 2.92 146.95 142.78 2.92 569.68 602.53 -5.45
PBT 61.48 7.64 704.71 61.48 7.64 704.71 343.53 -846.51 -140.58
TAX 22.12 -13.05 -269.50 22.12 -13.05 -269.50 90.34 -115.04 -178.53
Deferred Tax 22.12 -13.05 -269.50 22.12 -13.05 -269.50 90.34 -200.90 -144.97
PAT 39.36 20.69 90.24 39.36 20.69 90.24 253.19 -731.47 -134.61
Equity 224.26 224.26 0.00 224.26 224.26 0.00 224.26 224.26 0.00
PBIDTM(%) 9.06 9.18 -1.28 10.47 10.61 -1.28 8.84 6.41 37.98

Nectar Lifesciences Share Price

14.66 0.08 (0.55%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×